Skip to content

Author

D. Walt

We have 3 of 95 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Systematic Engineering of Human CD9 for Extracellular Vesicle Surface Display of Nanobodies Using Single-Vesicle Imaging.

This work engineer the human tetraspanin CD9 as a modular scaffold for displaying nanobodies on recombinant EV surfaces, using a high-throughput single-EV imaging platform to screen candidate constructs at the individual vesicle level and establishes single-EV imaging as a fast and quantitative screening tool for ident...

Arek V. Melkonian, Chung-Min Han, D. Walt · 0 citations
Review Oct 2026

Ultrasensitive Protein Detection in Cancer.

Circulating protein biomarkers may offer a minimally invasive way to diagnose and follow cancers, yet their clinical utility has been limited by biological and analytical constraints. Recent advances in ultrasensitive protein detection have enabled quantification of low-abundance analytes that were previously inaccessi...

Stephanie J. Zhang, Kathleen H. Burns, D. Walt · 0 citations
Open access Aug 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

BACKGROUND Post-acute sequelae of SARS-CoV-2 infection, more commonly known as long COVID, has emerged as a major health problem. The pathogenesis of long COVID is unknown, but among the leading hypotheses is viral persistence. We aimed to investigate whether the use of the SARS-CoV-2 antiviral nirmatrelvir-ritonavir i...

L. Baden, N. Shah, Sean T. H. Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.